Balloon Catheter Market by 2023 to 2033: Regional Insights and Forecasts
The global balloon catheter market is set to experience substantial growth over the next decade, with a projected compound annual growth rate (CAGR) of 4.3% from 2023 to 2033, according to a new report published today. Currently valued at approximately USD 4.2 billion, the market is expected to soar to USD 6.4 billion by the end of the forecast period, underscoring the vital role of balloon catheters in modern medical procedures.
This growth is driven by
ongoing innovation and technological advancements in balloon catheter design,
which are essential for performing increasingly complex medical procedures.
Industry leaders are at the forefront of developing state-of-the-art
technologies that enhance the efficiency, safety, and comfort of medical
interventions, thereby revolutionizing interventional cardiology and other
fields.
Key factors fueling this market expansion include:
- Rising
Prevalence of Cardiovascular Diseases: As cardiovascular diseases continue to
rise globally, the demand for effective and minimally invasive treatment
options, such as balloon catheters, is increasing.
- Aging
Population: With a growing geriatric population worldwide, there is a higher
demand for procedures that offer less recovery time and reduced surgical
risks.
- Demand for
Minimally Invasive Procedures: Patients and healthcare providers alike
are prioritizing less invasive treatment options, which has led to a surge
in the use of advanced balloon catheters.
Investments in research and
development are paving the way for the next generation of balloon catheters,
promising better patient outcomes and more efficient healthcare delivery. These
advancements are expected to meet the evolving needs of the healthcare sector,
providing medical professionals with tools that enhance procedural accuracy and
reduce recovery times for patients.
The report also highlights
the importance of strategic partnerships and collaborations among key market
players. These alliances are essential for accelerating innovation and
expanding market reach. By combining resources and expertise, industry leaders
can drive further advancements and unlock new growth opportunities within the
balloon catheter market.
Industry Outlook:
With a dynamic environment
for investment and development, the balloon catheter market is poised for
continued growth, offering significant opportunities for stakeholders,
including manufacturers, healthcare providers, and investors. As the global
healthcare landscape continues to evolve, the demand for advanced, efficient,
and safe medical devices like balloon catheters remains stronger than ever.
Key Takeaways from the Balloon Catheter Market:
- From 2023 to 2033, the United Kingdom market is likely to accelerate
at a CAGR of 4.8% and reach a value of USD 273.4 million in 2033.
- Germany market is also anticipated to expand at 4.7% CAGR and reach USD
244.3 million in 2033.
- The global balloon catheter market is expected to register 4.3% CAGR
between 2023 and 2033.
- A value of USD 6.4 billion is estimated for the global balloon
catheter market in the year 2033.
- The global balloon catheter market is poised to reach a valuation of
USD 4.2 billion in 2023.
- Rising prevalence of peripheral artery disease (PAD) is slated to
fuel the need for balloon catheters in Europe.
“As
peripheral artery disease is on rise in Europe, balloon catheter adoption is
expected to skyrocket in the coming years. Key players are focusing on
developing catheters that improve treatment outcomes.”– Says an
FMI Analyst.
Increased
Market Insight Demand: Get
Thorough Analysis and Trends in Our Complete Report!
Competition
Landscape in the Balloon Catheter Market:
To set themselves apart from
their rivals in the industry and boost sales in the global balloon catheter
market, manufacturing companies are concentrating on merger and acquisition
strategies.
- Boston Scientific Inc.,
- Medtronic,
- Terumo Corporation,
- B. Braun Melsungen AG,
- MicroPort Scientific Corporation,
- Jotech GmbH,
- QX Medical LLC,
- Meril Life Pvt. Ltd.,
- Hexacath,
- Abbott Laboratories
Recent
Developments:
·
In October
2022, Biosense
Webster, Inc., a Johnson & Johnson subsidy of medical technologies,
revealed its European debut of a HELIOSTAR balloon catheter, the first
radiofrequency balloon ablation catheter. It can be utilised for cardiac
ablation when coupled with a suitable cross RF generator and catheter-based
heart electrophysiological imaging of the atria.
·
In July 2021, PrevailTM drug coated
balloon (DCB) catheters were introduced in Europe under the CE (Conformité
Européenne) standard by Medtronic plc, a leading company in medical technology.
The Prevail DCB is used in percutaneous coronary intervention (PCI) treatments
to treat blocked or restricted blood vessels in people with cardiovascular
disease.
Key
Segments Profiled in the Balloon Catheter Market Survey:
By
Product Type:
- Normal
- Cutting
- Scoring
- Drug Eluting
- Others
By
Raw Material:
- Polyurethane
- Nylon
- Others
By
Indication:
- Coronary Artery Disease
- Peripheral Vascular Disease
By
End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
By
Region:
- North America
- Latin America
- Asia Pacific
- MEA
Comments
Post a Comment